JN: "101526829" - OpacWWW - Prolib Integro

Skocz do pozycji: 1 1.

Tytuł :: Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer.
Autorzy :: Kakarla M; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
ChallaSivaKanaka S; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Dufficy MF; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Gil V; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Filipovich Y; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Vickman R; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Crawford SE; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Hayward SW; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.
Franco OE; Department of Surgery, NorthShore University HealthSystem, Research Institute, 1001 University Place, Chicago, IL 60201, USA.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: Lung Cancer Screening: New Perspective and Challenges in Europe.
Autorzy :: Van Meerbeeck JP; Department of Thoracic Oncology, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium.
O'Dowd E; Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
Ward B; European Respiratory Society, Advocacy Department, 1000 Brussels, Belgium.
Van Schil P; Department of Thoracic and Vascular Surgery, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium.
Snoeckx A; Department of Radiology, Antwerp University and Antwerp University Hospital, 2650 Edegem, Belgium.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Analysis of Selected Nutritional Parameters in Patients with HPV-Related and Non-HPV-Related Oropharyngeal Cancer before and after Radiotherapy Alone or Combined with Chemotherapy.
Autorzy :: Brewczyński A; I Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Jabłońska B; Department of Digestive Tract Surgery, Medical University of Silesia, 40-752 Katowice, Poland.
Mazurek AM; Centre for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Mrochem-Kwarciak J; The Analytics and Clinical Biochemistry Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Mrowiec S; Department of Digestive Tract Surgery, Medical University of Silesia, 40-752 Katowice, Poland.
Śnietura M; Tumor Pathology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Kentnowski M; I Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Kotylak A; I Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Kołosza Z; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Składowski K; I Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Rutkowski T; I Radiation and Clinical Oncology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells.
Autorzy :: Wu CP; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan.
Hung CY; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Murakami M; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Wu YS; Department of Chemistry, Tunghai University, Taichung 40704, Taiwan.
Lin CL; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Huang YH; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Hung TH; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan.; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Yu JS; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Liver Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan 33302, Taiwan.
Ambudkar SV; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Long-Term Survival, Prognostic Factors, and Quality of Life of Patients Undergoing Pelvic Exenteration for Cervical Cancer.
Autorzy :: Stanca M; First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology 'G.E. Palade' of Târgu Mureș, Gheorghe Marinescu Street, Number 38, 540142 Târgu Mureș, Romania.
Căpîlna DM; First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology 'G.E. Palade' of Târgu Mureș, Gheorghe Marinescu Street, Number 38, 540142 Târgu Mureș, Romania.
Căpîlna ME; First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology 'G.E. Palade' of Târgu Mureș, Gheorghe Marinescu Street, Number 38, 540142 Târgu Mureș, Romania.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: Oncopeptide MBOP Encoded by LINC01234 Promotes Colorectal Cancer through MAPK Signaling Pathway.
Autorzy :: Tang C; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Zhou Y; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Sun W; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Hu H; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Liu Y; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Chen L; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Department of Clinical Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.; Westlake Laboratory of Life Sciences and Biomedicine of Zhejiang Province, Westlake University, Hangzhou 310024, China.
Ou F; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Zeng S; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Lin N; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Department of Clinical Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.; Westlake Laboratory of Life Sciences and Biomedicine of Zhejiang Province, Westlake University, Hangzhou 310024, China.
Yu L; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Department of Clinical Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy.
Autorzy :: Kim S; Department of Surgery, Korea University College of Medicine, Seoul 02841, Korea.; Department of Surgery, Korea University Ansan Hospital, Ansan 15355, Korea.
Lee CM; Department of Surgery, Korea University College of Medicine, Seoul 02841, Korea.; Department of Surgery, Korea University Ansan Hospital, Ansan 15355, Korea.
Lee D; Department of Surgery, Korea University Ansan Hospital, Ansan 15355, Korea.
Kim JH; Department of Surgery, Korea University College of Medicine, Seoul 02841, Korea.; Department of Surgery, Korea University Guro Hospital, Seoul 08308, Korea.
Park S; Department of Surgery, Korea University College of Medicine, Seoul 02841, Korea.; Department of Surgery, Korea University Anam Hospital, Seoul 02841, Korea.
Park SH; Department of Surgery, Korea University College of Medicine, Seoul 02841, Korea.; Department of Surgery, Korea University Anam Hospital, Seoul 02841, Korea.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.
Autorzy :: Jones AB; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Rocco A; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Lamb LS; IN8bio Inc., New York, NY 10016, USA.
Friedman GK; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Hjelmeland AB; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 9 9.

Tytuł :: Calcium Channel Blocker Use and the Risk for Breast Cancer: A Population-Based Nested Case-Control Study.
Autorzy :: Rotshild V; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel.; The Department of Pharmacy, Clalit Health Services, Jerusalem District, Jerusalem 9112002, Israel.
Hirsh Raccah B; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel.; Department of Cardiology, Hadassah University Hospital Ein Karem, Jerusalem 9112002, Israel.
Gazawe M; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel.
Matok I; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 10 10.

Tytuł :: Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.
Autorzy :: Gül D; Department of Otorhinolaryngology, Head and Neck Surgery, Molecular and Cellular Oncology, University Medical Center, 55131 Mainz, Germany.
Schweitzer A; Department of Otorhinolaryngology, Head and Neck Surgery, Molecular and Cellular Oncology, University Medical Center, 55131 Mainz, Germany.
Khamis A; Department of Otorhinolaryngology, Head and Neck Surgery, Molecular and Cellular Oncology, University Medical Center, 55131 Mainz, Germany.; Oral Pathology Department, Faculty of Dentistry, Alexandria University, El Azareta, Alexandria, Egypt.
Knauer SK; Institute for Molecular Biology, Centre for Medical Biotechnology (ZMB), University Duisburg-Essen, Universitätsstraße, 45117 Essen, Germany.
Ding GB; Institute of Biotechnology, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan 030006, China.
Freudelsperger L; Department of Otorhinolaryngology, Head and Neck Surgery, Molecular and Cellular Oncology, University Medical Center, 55131 Mainz, Germany.
Karampinis I; Academic Thoracic Center, University Medical Center Mainz, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Strieth S; Department of Otorhinolaryngology, University Medical Center Bonn, 53127 Bonn, Germany.
Hagemann J; Department of Otorhinolaryngology, Head and Neck Surgery, Molecular and Cellular Oncology, University Medical Center, 55131 Mainz, Germany.
Stauber RH; Department of Otorhinolaryngology, Head and Neck Surgery, Molecular and Cellular Oncology, University Medical Center, 55131 Mainz, Germany.; Institute of Biotechnology, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan 030006, China.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 11 11.

Tytuł :: Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis.
Autorzy :: García-Fortes M; Hematology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.; Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.
Hernández-Boluda JC; Hematology Department, Hospital Clínico, INCLIVA, 46010 Valencia, Spain.
Álvarez-Larrán A; Hematology Department, Hospital Clínic, 08036 Barcelona, Spain.
Raya JM; Hematology Department, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain.
Angona A; Hematology Department, Hospital del Mar, 08003 Barcelona, Spain.
Estrada N; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, 08916 Badalona, Spain.
Fox L; Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain.
Cuevas B; Hematology Department, Hospital Universitario de Burgos, 09006 Burgos, Spain.
García-Hernández MC; Hematology Department, Hospital General Universitario de Alicante, 03010 Alicante, Spain.
Gómez-Casares MT; Hematology Department, Hospital Universitario Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Ferrer-Marín F; Hematology Department, Hospital General Universitario Morales Meseguer, CIBERER, IMIB, UCAM, 30008 Murcia, Spain.
Saavedra S; Hematology Department, Hospital Santa Creu i Sant Pau, 08025 Barcelona, Spain.
Cervantes F; Hematology Department, Hospital Clínic, 08036 Barcelona, Spain.
García-Delgado R; Hematology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
On Behalf Of The Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas Gemfin; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: Regulation of Carcinogenesis by Sensory Neurons and Neuromediators.
Autorzy :: Erin N; Department of Medical Pharmacology, Immunopharmacology, and Immuno-Oncology Unit, School of Medicine, Akdeniz University, 07070 Antalya, Turkey.
Shurin GV; Department of Pathology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, 15213 PA, USA.
Baraldi JH; Department of Neuroscience, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, 15213 PA, USA.
Shurin MR; Department of Pathology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, 15213 PA, USA.; Department of Immunology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, 15213 PA, USA.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.
Autorzy :: Labrador J; Hematology Department, Research Unit, Complejo Asistencial Universitario de Burgos, 09006 Burgos, Spain.
Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politécnic La Fe, 46026 Valencia, Spain.
de la Fuente A; Hematology Department, MD Anderson Cancer Center Madrid, 28033 Madrid, Spain.
Rodríguez-Veiga R; Hematology Department, Hospital Universitari i Politécnic La Fe, 46026 Valencia, Spain.
Serrano J; Hematology Department, Hospital Universitario Reina Sofía, IMIBIC, 14004 Córdoba, Spain.
Tormo M; Hematology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria-INCLIVA, 46010 Valencia, Spain.
Rodriguez-Arboli E; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), 41013 Sevilla, Spain.
Ramos F; Hematology Department, Hospital Universitario de León, 24071 León, Spain.
Bernal T; Hematology Department, Hospital Universitario Central Asturias, ISPA, IUOPA, 33011 Oviedo, Spain.
López-Pavía M; Hematology Department, Hospital General de Valencia, 46026 Valencia, Spain.
Trigo F; Hematology Department, Centro Hospitalar Universitário de São João, 4200-319 Porto, Portugal.
Martínez-Sánchez MP; Hematology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Rodríguez-Gutiérrez JI; Hematology Department, Hospital Universitario Basurto, 48013 Bilbao, Spain.
Rodríguez-Medina C; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Gil C; Hematology Department, Hospital General Universitario de Alicante, 03010 Alicante, Spain.
Belmonte DG; Hematology Department, Hospital Universitario Sanitas La Zarzuela, 28023 Madrid, Spain.
Vives S; Hematology Department, Hospital Germans Trias i Pujol-ICO, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Foncillas MÁ; Hematology Department, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.
Pérez-Encinas M; Hematology Department, Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
Novo A; Hematology Department, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain.
Recio I; Hematology Department, Complejo Asistencial de Ávila, 05071 Avila, Spain.
Rodríguez-Macías G; Hematology Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Bergua JM; Hematology Department, Hospital San Pedro de Alcántara, 10003 Caceres, Spain.
Noriega V; Hematology Department, Hospital Universitario de A Coruña, 15006 La Coruna, Spain.
Lavilla E; Hematology Department, Hospital Universitario Lucus Augusti, 27003 Lugo, Spain.
Roldán-Pérez A; Hematology Department, Hospital Universitario Infanta Sofía, 28702 San Sebastián de los Reyes, Spain.
Sanz MA; Hematology Department, Hospital Universitari i Politécnic La Fe, 46026 Valencia, Spain.
Montesinos P; Hematology Department, Hospital Universitari i Politécnic La Fe, 46026 Valencia, Spain.
On Behalf Of Pethema Group; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.
Autorzy :: Bonsang-Kitzis H; Gynecological and Breast Surgery and Cancerology Center, RAMSAY-Générale de Santé, Hôpital Privé des Peupliers, 75013 Paris, France.; GINECO/TMRG Network, 75008 Paris, France.
Panchbhaya N; Department of Obsterics and Gynecology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 75020 Paris, France.
Bats AS; Department of Breast and Gynecological Surgical Oncology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 75015 Paris, France.; School of Medicine, Université de Paris, 75005 Paris, France.
Pujade-Lauraine E; GINECO/TMRG Network, 75008 Paris, France.; School of Medicine, Université de Paris, 75005 Paris, France.; Women Cancer Center and Clinical Research, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, 75006 Paris, France.
Pautier P; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Institut Gustave Roussy, 94000 Villejuif, France.
Ngô C; Gynecological and Breast Surgery and Cancerology Center, RAMSAY-Générale de Santé, Hôpital Privé des Peupliers, 75013 Paris, France.; GINECO/TMRG Network, 75008 Paris, France.
Le Frère-Belda MA; GINECO/TMRG Network, 75008 Paris, France.; Department of Pathology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 75015 Paris, France.
Kalbacher E; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Hôpital Jean Minjoz, 25000 Besançon, France.
Floquet A; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Institut Bergonié, 33000 Bordeaux, France.
Berton-Rigaud D; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Institut de Cancérologie de l'Ouest-René Gauducheau, 44000 Saint Herblain, France.
Lefeuvre-Plesse C; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Centre Eugène Marquis, 35000 Rennes, France.
Fabbro M; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Institut Régional du Cancer de Montpellier, 33000 Montpellier, France.
Ray-Coquard I; GINECO/TMRG Network, 75008 Paris, France.; Department of Medical Oncology, Centre Léon Bérard, 69000 Lyon, France.; School of Medicine, Claude Bernard University, 69000 Lyon, France.
Lécuru F; GINECO/TMRG Network, 75008 Paris, France.; Women Cancer Center and Clinical Research, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, 75006 Paris, France.; Department of Breast, Gynecology and Reconstructive Surgery, Institut Curie, 75005 Paris, France.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer.
Autorzy :: Nam S; Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon 21999, Korea.; Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Korea.
Lee Y; Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon 21999, Korea.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 09; Vol. 14 (9). Date of Electronic Publication: 2022 May 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Correlation between Colon Perfusion and Postoperative Fecal Output through a Transanal Drainage Tube during Laparoscopic Low Anterior Resection.
Autorzy :: Kawada K; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Wada T; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.; Department of Surgery, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan.
Yamamoto T; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.; Department of Gastroenterological Surgery and Oncology, Kitano Hospital Medical Research Institute, Osaka 530-8480, Japan.
Itatani Y; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Hida K; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Obama K; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 08; Vol. 14 (9). Date of Electronic Publication: 2022 May 08.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?
Autorzy :: Małkiewicz B; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Knura M; Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
Łątkowska M; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Kobylański M; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Nagi K; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Janczak D; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Chorbińska J; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Krajewski W; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Karwacki J; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.
Szydełko T; Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-566 Wroclaw, Poland.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 08; Vol. 14 (9). Date of Electronic Publication: 2022 May 08.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer.
Autorzy :: Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Sandrini E; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Hoeltgen L; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Hoegen P; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
König L; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Arians N; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center, New York University Langone Health, New York, NY 10023, USA.
Wallwiener M; Department of Gynecology and Obstetrics, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Weis I; Social Service Counselling, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Roob D; Social Service Counselling, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Debus J; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), 69120 Heidelberg, Germany.; German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, 69120 Heidelberg, Germany.
Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, 69120 Heidelberg, Germany.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 08; Vol. 14 (9). Date of Electronic Publication: 2022 May 08.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors.
Autorzy :: Polomski EAS; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Heemelaar JC; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Krol ADG; Department of Radiotherapy, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Louwerens M; Department of Internal Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Beeres SLMA; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Holman ER; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Jukema JW; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Schalij MJ; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Antoni ML; Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 08; Vol. 14 (9). Date of Electronic Publication: 2022 May 08.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 20 20.

Tytuł :: Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins.
Autorzy :: Buchou C; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Laud-Duval K; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
van der Ent W; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Grossetête S; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Zaidi S; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Gentric G; INSERM U830, Équipe Labellisée LNCC, Stress and Cancer Laboratory, PSL Research University, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Corbé M; Department of Translational Research, The Biophenics High-Content Screening Laboratory, PSL Research University, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Müller K; Department of Translational Research, The Biophenics High-Content Screening Laboratory, PSL Research University, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Del Nery E; Department of Translational Research, The Biophenics High-Content Screening Laboratory, PSL Research University, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.
Surdez D; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.; Balgrist University Hospital, University of Zurich, Zurich, Forchstrasse 340, 8008 Zürich, Switzerland.
Delattre O; INSERM U830, Équipe Labellisée LNCC, Diversity & Plasticity of Childhood Tumors Laboratory, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, 26 rue d'ULM, 75005 Paris, France.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 May 08; Vol. 14 (9). Date of Electronic Publication: 2022 May 08.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""101526829"" wg kryterium: JN

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język